Phase 2 N=42 Anti-Hormone Therapy (With Anastrazole and Fulvestrant) Before Surgery to Treat Postmenopausal Women With Breast Cancer.
Invasive Breast Cancer
Primary: Pathologic Complete Response (PCR) Rate — 0 participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 3 N=3,871 Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer
Breast Cancer
Primary: Relapse Free Survival (RFS) 4 vs. 6 Cycles — NA; NA years
Phase 2 N=26 Lenalidomide in Patients With Chronic Lymphocytic Leukemia Older Than 65 Years of Age
Chronic Lymphocytic Leukemia · Leukemia
Primary: Best Response — 20; 3; 3 Participants
N/A N=240 The Effects of Treating Obese and Lean Patients With Sleep Apnea
Sleep Apnea · Obesity
Primary: Change From Baseline in Mean Arterial Blood Pressure — -4.21; -0.95 mm Hg
N/A N=65 Comparison of 2 Laryngoscopes for Endotracheal Intubation in Children Younger Than 2 Years Old
Endotracheal Intubation
Primary: Measurement of Time to Intubation Will Begin at the Time of Mouth Opening and End With the Removal of the Tip of the Laryngoscope Blade From the Patient's Mouth After…
Phase 2 N=9 Investigation of Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Efficacy of Oral Danirixin in Symptomatic COPD Subjects With Mild to Moderate Airflow Limitation at Risk for Exacerbations
Pulmonary Disease, Chronic Obstructive
Primary: Number of Participants With Any Adverse Event (AE) and, Serious Adverse Event (SAE) in Part A — 5; 1 Participants
N/A N=111 Hyaluronic Acid vs Platelet Rich Plasma: Effects on Clinical Outcomes and Intra-articular Biology for the Treatment of Knee Osteoarthritis
Osteoarthritis, Knee
Primary: International Knee Documentation Committee Score (IKDC — 65.5; 55.8 units on a scale
N/A N=70 Mechanisms of Endothelial Cell Dysfunction in Sleep Apnea
Obstructive Sleep Apnea · Hypoxemia
Primary: ODI — 24.71; .97 events/hour
Phase 4 N=60 Oral Steroids Before Pulmonary Vein Isolation to Improve Outcomes
Atrial Fibrillation
Primary: Number of Participants With Atrial Fibrillation Recurrence From 6 Months up to 12 Months — 4; 6 Participants with AF recurrence
Phase 2 N=50 Combination Chemotherapy and Peripheral Blood Stem Cell Transplant Followed By Aldesleukin and Sargramostim in Treating Patients With Inflammatory Stage IIIB or Metastatic Stage IV Breast Cancer
Estrogen Receptor-negative Breast Cancer · Estrogen Receptor-positive Breast Cancer · Inflammatory Breast Cancer
Primary: Event-free Survival — 11; 9 Participants
N/A N=21 Auditory-somatosensory Stimulation to Alleviate Tinnitus
Tinnitus
Primary: Change in TFI (Tinnitus Functional Index) After Treatment or Sham Compared to Baseline — -10.08; -5.40; 0.95; -4.34 units on a scale — p=<0.05
N/A N=101 Effect Of Biomechanical Stimulation On Skeletal Health In Adolescent And Young Women With Anorexia Nervosa
Anorexia Nervosa
Primary: Change From Baseline in C-telopeptides — 0.083; -0.027 ng/mL/day
N/A N=14 Flecainide for Catecholaminergic Polymorphic Ventricular Tachycardia
Catecholaminergic Polymorphic Ventricular Tachycardia
Primary: Number of Patients With Ventricular Ectopy or VT During Exercise Treadmill Testing — 2; 9 Participants — p=0.008
Phase 4 N=10 Study of Ranolazine in the Treatment of Pulmonary Hypertension Associated With Diastolic Left Ventricular Dysfunction
Pulmonary Hypertension · Diastolic Left Ventricular Dysfunction
Primary: Percent Change in mPAP, PAOP and Pulmonary Vascular Resistance (PVR) — -21; -39; -4.0 percentage change
N/A N=1,014 Registry Study of Genesys HTA for Treatment of Menorrhagia
Menorrhagia
Primary: Burn Rate — 4 participants